Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Julie Errington

Newcastle AuthorsTitleYearFull text
Julie Errington
Dr Shelby Barnett
Professor Gareth Veal
Spontaneous fractures during 13-cis retinoic acid therapy for neuroblastoma2023
Dr Catherine Gowland
Philip Berry
Julie Errington
Professor Gareth Veal
Development of a LC-MS/MS method for the quantification of toxic payload DM1 cleaved from BT1718 in a Phase I study2021
Dr Shelby Barnett
Julie Errington
Julieann Sludden
Dr David Jamieson
Professor Gareth Veal
Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population2021
Professor Gareth Veal
Professor Deborah Tweddle
Julie Errington
Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: A randomized crossover clinical trial2021
Dr Rosanna Jackson
Philip Berry
Julie Errington
Professor Julie Irving
Professor Gareth Veal
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia - a report from the UKALL 2011 trial2019
Professor Gareth Veal
Julie Errington
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: A re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function2019
Professor Gareth Veal
Julie Errington
Dr Leigh McDonald
Professor Deborah Tweddle
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compression2019
Professor Gareth Veal
Julie Errington
Adaptive dosing of anticancer drugs in neonates – facilitating evidence-based dosing regimens2016
Professor Gareth Veal
Julieann Sludden
Dr David Jamieson
Julie Errington
Dr Ghada Malik
et al.		Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin’s lymphoma2016
Julie Errington
Dr Ghada Malik
Lisa Price
Professor Gareth Veal
Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK2016
Professor Gareth Veal
Julie Errington
Dr James Hayden
Professor Deborah Tweddle
Carboplatin therapeutic monitoring in preterm and full-term neonates2015
Professor Gareth Veal
Julie Errington
Dr James Hayden
Professor Deborah Tweddle
Carboplatin therapeutic monitoring in preterm and full-term neonates2015
Professor Gareth Veal
Julie Errington
Professor Deborah Tweddle
Therapeutic drug monitoring approaches to the treatment of preterm and full-term neonates with cancer - A UK experience2015
Dr Chris Hill
Julie Errington
Dr Ghada Malik
Professor Alan Boddy
Professor Gareth Veal
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer2014
Professor Gareth Veal
Julie Errington
Sophie Rowbotham
Nicola Illingworth
Dr Ghada Malik
et al.		Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastoma2013
123